Navigation Links
Annual Economic Impact of Chronic Disease on Ohio Economy is $56.8 Billion
Date:3/20/2008

Impact not inevitable with improved treatment and prevention of chronic

disease

CLEVELAND, March 20 /PRNewswire-USNewswire/ -- In a groundbreaking study released by the Milken Institute, the annual economic impact on Ohio's economy of the most common chronic diseases is calculated to be $56.8 billion. In the U.S. as a whole, the cost is a staggering $1 trillion, which could balloon to nearly $6 trillion by the middle of the century. Yet the news is not entirely grim because much of this cost is avoidable.

"An Unhealthy America: The Economic Burden of Chronic Disease" brings to light for the first time what is often overlooked in the discussion of the impact of chronic disease -- the economic loss associated with preventable illness and the cost to the nation's Gross Domestic Product (GDP) and American businesses in lost growth.

The results of the study were released at a joint forum hosted today by the Cleveland Clinic, University Hospitals, Rainbow Babies & Children's Hospital, the City of Cleveland Health Department and Cuyahoga County Board of Health, and the Ohio chapter of the Partnership to Fight Chronic Disease.

"The human toll of chronic disease in Ohio and the United States as a whole is obvious," said Matt Carroll, Health Director for the City of Cleveland. "The data presented by the Milken Institute today highlights the true cost burden of our failure to address chronic disease. We must reduce the rate of chronic disease to avoid potentially devastating economic damage to our state and nation."

According to the study, seven chronic diseases -- cancer, diabetes, hypertension, stroke, heart disease, pulmonary conditions and mental illness -- have a total impact on Ohio's economy of nearly $56.8 billion annually. Of this amount, $43.4 billion represents the cost of lost productivity. The national numbers are $1.3 trillion and $1.1 trillion, respectively.

"By investing in good
'/>"/>

SOURCE The Partnership to Fight Chronic Disease; The MilkenInstitute
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. NARSADs 5th Annual Mission Possible Symposium Offers Insight to PTSD and Other Mental Illnesses
2. Mirion Technologies to Showcase New Product Offerings for the Nuclear Industry During 10th Annual China International Nuclear Industry Exhibition
3. Abaxis, Inc. to Present at the Sidoti & Company Twelfth Annual New York Emerging Growth Institutional Investor Forum
4. ULURU Inc. to Present at Cowen and Company 28th Annual Health Care Conference 2008
5. Transdel Pharmaceuticals to Present at Cowen and Companys 28th Annual Health Care Conference
6. Flagship Global Health Announces Annual Meeting
7. Transition Therapeutics to Present at Cowen & Company 28th Annual Healthcare Conference
8. Covance to Present at Lehman Brothers 11th Annual Global Healthcare Conference
9. West Pharmaceutical Services to Present at the Lehman Brothers Eleventh Annual Global Healthcare Conference
10. Exelixis Announces March 19 Webcast of Presentation at the Lehman Brothers Annual Global Healthcare Conference
11. Edwards Lifesciences to Present at the Citi 5th Annual Small and Mid-Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... TX (PRWEB) , ... August 01, 2015 , ... BeverlyD, ... for the March4thforWellBeing foundation, making hers the very first small business donation to kick ... look beautiful for over thirty years. Her legacy includes a complete line of raw, ...
(Date:7/31/2015)... NV (PRWEB) , ... July 31, 2015 , ... Ticket Down is a reputable source ... at the MGM Grand Garden Arena. Fans of every genre of music will have ... September 18th, the first day of the festival, the following artists will perform: Sam ...
(Date:7/31/2015)... ... 2015 , ... Ticket Down is a reliable source for authentic tickets for ... Park. The festival will end on Sunday, August 2nd. , Music ... Lollapalooza. This unique and unbelievably popular festival attracts the best in entertainment from ...
(Date:7/31/2015)... ... 2015 , ... The 2nd annual Ride to Fight On will start and ... 2015. The Ride to Fight On is a cycling fundraiser that benefits the West ... Clinic and The University of Tennessee Health Science Center. A health and wellness festival ...
(Date:7/31/2015)... ... July 31, 2015 , ... Facebook, Twitter, Linkedin ... re-branded their social media profiles to better connect with the public. The agency ... find information, share insights and opinions. The Rally Insurance Group, Inc.’s pledge to ...
Breaking Medicine News(10 mins):Health News:March4thforWellBeing Foundation Kickoff 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 2Health News:Cheap 2015 iHeartRadio Music Festival Tickets in Las Vegas at MGM Grand Garden Arena: Ticket Down Slashes Ticket Prices on the iHeart Radio Music Festival in Vegas 3Health News:Cheap 2015 Lollapalooza Tickets: Ticket Down Slashes Ticket Prices on Lollapalooza Tickets at Grant Park in Chicago for Saturday, August 1st and Sunday, August 2nd 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 2Health News:West Cancer Center Announces 2nd Annual Ride to Fight On 3Health News:Rally Insurance Group, Inc. Connects to Customers Through Re-branded Social Media Profiles 2
... ST. PAUL, Minn., Sept. 10 . Two heroes of ... New York,s Hudson River last January will visit the Twin Cities ... fundraiser. , , Patrick Harten , the ... choose an emergency response, and cool-headed flight attendant Doreen Welsh ...
... MALVERN, Pa., Sept. 10 Ascenta Therapeutics announced today that following ... its Investigational New Drug (IND) Application for AT-406, an orally-active, small ... trial in patients with advanced cancer during the fourth quarter of ... ) , , "We are very pleased ...
... TORONTO, Sept. 10 /PRNewswire-FirstCall/ - MDS Inc. (TSX: MDS; NYSE: ... the global life sciences markets, today reported financial results for the ... $199 million, a net loss of $62 million and a loss ... with $252 million in total revenue, a net loss of $10 ...
... , ARMONK, N.Y., Sept. 10 ... (CIOs), released by IBM (NYSE: IBM ) today, ... business decision-making is now the top priority for CIOs. More than ... and analytics - the ability to see patterns in vast amounts ...
... , , LONG BEACH, Calif., Sept. 10 ... this system is you. All I ask in return for using my system ... said Bob Ainuu Afamasaga. , , "Millions of Europeans ... mind because, as I have already said several times, creating debt is no solution..." ...
... ... Shepherd presented at this year,s Pennsylvania Association for Justice (PaAJ) "Pennsylvania Master Series, ... , ... PA (PRWEB) September 10, 2009 -- Feldman, Shepherd, Wohlgelernter, Tanner, Weinstock & Dodig ...
Cached Medicine News:Health News:Wings of Mercy Benefit Features 'Miracle on the Hudson' Heroes 2Health News:Wings of Mercy Benefit Features 'Miracle on the Hudson' Heroes 3Health News:Ascenta Therapeutics Receives Clearance to Initiate Clinical Trials With AT-406 2Health News:MDS Reports Third Quarter 2009 Financial Results 2Health News:MDS Reports Third Quarter 2009 Financial Results 3Health News:MDS Reports Third Quarter 2009 Financial Results 4Health News:MDS Reports Third Quarter 2009 Financial Results 5Health News:MDS Reports Third Quarter 2009 Financial Results 6Health News:MDS Reports Third Quarter 2009 Financial Results 7Health News:MDS Reports Third Quarter 2009 Financial Results 8Health News:MDS Reports Third Quarter 2009 Financial Results 9Health News:MDS Reports Third Quarter 2009 Financial Results 10Health News:MDS Reports Third Quarter 2009 Financial Results 11Health News:MDS Reports Third Quarter 2009 Financial Results 12Health News:MDS Reports Third Quarter 2009 Financial Results 13Health News:MDS Reports Third Quarter 2009 Financial Results 14Health News:MDS Reports Third Quarter 2009 Financial Results 15Health News:MDS Reports Third Quarter 2009 Financial Results 16Health News:MDS Reports Third Quarter 2009 Financial Results 17Health News:MDS Reports Third Quarter 2009 Financial Results 18Health News:MDS Reports Third Quarter 2009 Financial Results 19Health News:MDS Reports Third Quarter 2009 Financial Results 20Health News:MDS Reports Third Quarter 2009 Financial Results 21Health News:MDS Reports Third Quarter 2009 Financial Results 22Health News:MDS Reports Third Quarter 2009 Financial Results 23Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 2Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 3Health News:New IBM Study Highlights Analytics as Top Priority for Today's CIO 4Health News:$0.00 Penny System to Jump Start Global Economy Developed by DNA and MIND Researcher. 2Health News:Philadelphia Attorney Carol Nelson Shepherd Presents at the 2009 Pennsylvania Association for Justice Master Series 2
(Date:7/30/2015)...  Amgen (NASDAQ: AMGN ) today announced ... Key results include: , Total revenues increased ... to $5,370 million, with 6 percent product sales ... Prolia ® (denosumab), Sensipar ® (cinacalcet), ... (denosumab). Unfavorable changes in foreign exchange rates impacted ...
(Date:7/30/2015)... 30, 2015  Amgen (NASDAQ: AMGN ) today announced ... director of Warburg Pincus LLC, to the Amgen Board of ... Fred Hassan and the deep, global experience he brings ... Robert A. Bradway , chairman and chief executive officer of Amgen. ... serve Amgen well." Mr. Hassan has been Partner ...
(Date:7/30/2015)...  Cleveland Clinic President Wael Barsoum , M.D. ... that industry is compelled to adopt declining reimbursements throughout ... develop the transformational innovations -- required to thrive in ... by Doug Kohrs , past President and CEO ... that industry must add "episode of care," also known ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... 2010 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) ... trial.  The Company has now completed the final trial necessary ... plans to submit an NDA in the first half of ... has completed Phase 3 clinical development for the acute treatment ...
... Inc. today announced $3 million in Convertible Note funding. ... Phase II trials of BPX-101, the company,s DeCIDe™ vaccine ... a cell therapy safety switch under initial development in ... The new funding brings the total raised to date ...
Cached Medicine Technology:MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 2MAP Pharmaceuticals Announces Completion of LEVADEX™ Open-Label Safety Trial 3Bellicum Pharmaceuticals Announces $3 Million in Convertible Note Funding 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: